ArticleThe Lancet. Global health2022

The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.

Global Retinoblastoma Study GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.